Lawrence G. Hamel
2012
In 2012, Lawrence G. Hamel earned a total compensation of $516.1K as Chief Development Officer at AcelRx Pharmaceuticals, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $95,160 |
|---|---|
| Option Awards | $120,600 |
| Salary | $292,800 |
| Other | $7,500 |
| Total | $516,060 |
Hamel received $292.8K in salary, accounting for 57% of the total pay in 2012.
Hamel also received $95.2K in non-equity incentive plan, $120.6K in option awards and $7.5K in other compensation.
Rankings
In 2012, Lawrence G. Hamel's compensation ranked 8,667th out of 11,487 executives tracked by ExecPay. In other words, Hamel earned more than 24.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,667 out of 11,487 | 25th |
Division Manufacturing | 3,153 out of 4,253 | 26th |
Major group Chemicals And Allied Products | 843 out of 1,198 | 30th |
Industry group Drugs | 616 out of 920 | 33rd |
Industry Pharmaceutical Preparations | 482 out of 700 | 31st |
Source: SEC filing on April 30, 2015.
Hamel's colleagues
We found four more compensation records of executives who worked with Lawrence G. Hamel at AcelRx Pharmaceuticals in 2012.